Application Note
IsoPlexis Proteomic Product Suite for CAR-T Therapy

Learn how IsoPlexis’ functional proteomics reveals unique secretomic signatures and insights into CAR-T therapy.

Download Resource

Your Data is Secure

We will always keep your personal information safe and not share it with any third parties. By submitting this form, you agree to receive communications from IsoPlexis and accept our Privacy Policy.

You may unsubscribe and update your email subscription at any time.

IsoPlexis Proteomic Product Suite for CAR-T Therapy

Learn how IsoPlexis’ functional proteomics reveals unique secretomic signatures and insights into CAR-T therapy.

In this Application Note we discuss:
  • Overcoming challenges in CAR-T therapy
  • Overcoming antigen escape in Multiple Myeloma
  • Comparing subtle gene edits in NK cell therapies
  • Preinfusion biomarkers for predicting clinical outcome in CAR-T cell treatment